{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:23:14Z","timestamp":1777321394775,"version":"3.51.4"},"reference-count":32,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1562,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1439-0507.2010.02009.x","type":"journal-article","created":{"date-parts":[[2011,5,23]],"date-time":"2011-05-23T10:54:05Z","timestamp":1306148045000},"page":"523-530","source":"Crossref","is-referenced-by-count":19,"title":["Serum galactomannan strongly correlates with outcome of invasive aspergillosis in acute leukaemia patients"],"prefix":"10.1111","volume":"54","author":[{"given":"Sun Hee","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Mi","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Gun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Hyun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Cheol","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hong","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Je","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Seong","family":"Eom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo-Sung","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,5,23]]},"reference":[{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1086\/591531","article-title":"Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study","volume":"47","author":"Slobbe","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2165\/00003495-200767110-00004","article-title":"Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients","volume":"67","author":"Maschmeyer","year":"2007","journal-title":"Drugs"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3324\/haematol.2009.012054","article-title":"Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study","volume":"95","author":"Pagano","year":"2010","journal-title":"Haematologica"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1086\/649879","article-title":"Fungal infections in leukemia patients: how do we prevent and treat them?","volume":"50","author":"Leventakos","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.22738","article-title":"Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: proof of principle, description, and clinical and research implications","volume":"110","author":"Miceli","year":"2007","journal-title":"Cancer"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1086\/514352","article-title":"Trial design for mold-active agents: time to break the mold - aspergillosis in neutropenic adults","volume":"44","author":"Anaissie","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1473-3099(05)70238-3","article-title":"Laboratory diagnosis of invasive aspergillosis","volume":"5","author":"Hope","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1473-3099(04)01045-X","article-title":"Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis","volume":"4","author":"Mennink-Kersten","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/cncr.24022","article-title":"Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients","volume":"115","author":"Maertens","year":"2009","journal-title":"Cancer"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/cncr.22863","article-title":"Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer","volume":"110","author":"Woods","year":"2007","journal-title":"Cancer"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/339324","article-title":"Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease","volume":"34","author":"Boutboul","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1469-0691.2008.02122.x","article-title":"Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis","volume":"15","author":"Cordonnier","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1086\/528714","article-title":"Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications","volume":"46","author":"Miceli","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1086\/528715","article-title":"Aspergillus galactomannan index: a surrogate end point to assess outcome of therapy?","volume":"46","author":"Marr","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jac\/dkm463","article-title":"False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation","volume":"61","author":"Asano-Mori","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1469-0691.2008.02122.x","article-title":"Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis","volume":"15","author":"Cordonnier","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1111\/j.1439-0507.2010.02009.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1439-0507.2007.01375.x","article-title":"Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders","volume":"50","author":"Maertens","year":"2007","journal-title":"Mycoses"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 2","key":"10.1111\/j.1439-0507.2010.02009.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1007\/s00277-003-0764-4","article-title":"Antimicrobial therapy of unexplained fever in neutropenic patients - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society)","volume":"82","author":"Link","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/cncr.23441","article-title":"Changes in causes of death over time after treatment for invasive aspergillosis","volume":"112","author":"Wingard","year":"2008","journal-title":"Cancer"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/sim.1180","article-title":"Kappa coefficients in medical research","volume":"21","author":"Kraemer","year":"2002","journal-title":"Stat Med"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/422009","article-title":"Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance","volume":"190","author":"Marr","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3346\/jkms.2005.20.1.31","article-title":"Prognostic factors influencing infection-related mortality in patients with acute leukemia in Korea","volume":"20","author":"Yoo","year":"2005","journal-title":"J Korean Med Sci"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1080\/10428190802353609","article-title":"Outcome and prognostic factors of patients with acute leukemia admitted to the intensive care unit for septic shock","volume":"49","author":"Park","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1086\/422151","article-title":"False-positive Aspergillus galactomannan antigen test results","volume":"39","author":"Maertens","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/383148","article-title":"Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies","volume":"38","author":"Adam","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1439-0507.2008.01652.x","article-title":"Galactomannan on the stage: prospective evaluation of the applicability in routine practice and surveillance","volume":"53","author":"Tanriover","year":"2010","journal-title":"Mycoses"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1086\/427284","article-title":"Application of nucleic acid sequence-based amplification for diagnosis of and monitoring the clinical course of invasive aspergillosis in patients with hematologic diseases","volume":"40","author":"Yoo","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1439-0507.2010.02009.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1086\/499949","article-title":"The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting","volume":"42","author":"White","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.2010.02009.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1439-0507.2010.02009.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T04:37:20Z","timestamp":1625632640000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.2010.02009.x"}},"subtitle":["Galactomannan correlates with outcome of IA"],"short-title":[],"issued":{"date-parts":[[2011,5,23]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.2010.02009.x","relation":{},"ISSN":["0933-7407"],"issn-type":[{"value":"0933-7407","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5,23]]}}}